Skip to main content
. 2019 Nov 25;102(1):69–77. doi: 10.4269/ajtmh.18-0242

Table 1.

Self-reported demographics of clinically diagnosed participants

Residence Gender Age When infected Where infected Diagnosis procedure Hospital admission %EV Dot blot
Pahoa F 68 1981 Honokaa or Hilo Spinal tap HMC 18 P
Pahoa M 52 2004 Kapoho (Puna) Spinal tap QMC 58 N
Pahoa F 63 2005 Kapoho (Puna) Antibody test NR 27 N
Pahoa M 67 2007 Pahoa (Puna) Eosinophil test NR 60 P
Hilo M 30 2008 Kapoho (Puna) Spinal tap HMC 53 N
Pahoa M 70 2009 Papaya Farms Rd (Puna) Other Thailand 69 P
Pahoa F 12 2009 Puna, HI Spinal Tap HMC 48 N
Pahoa M 73 2009 Pahoa (Puna) Symptoms NR 16 N
Keaau F 62 2010 Hawaii Don't Know NR 38 N
Hilo F 39 2014 Hilo Spinal Tap/CT HMC 100 P
Hilo M 39 2014 Hilo Spinal tap HMC 70 P
Hilo F 55 2014 Keaau (Puna) Ab test NR 32 N
Pahoa M 23 2015 Puna Spinal tap HMC 111 P
Pahoa M 73 2015 Puna Antibody test HMC 87 P
Pahoa F 59 2015 Puna Symptoms and response to treatment NR 69 N

HMC = Hilo Medical Center (Hilo); QMC = Queen’s Medical Center (Honolulu); all were diagnosed by MD or ND. NR = no response; M = male; F = female. The %EV is the ELISA value, and dot blot is listed as positive (P) or negative (N).